Related Experiment Videos
Basidiospore extracts: evidence for common antigenic/allergenic determinants.
C E O'Neil1, J M Hughes, B T Butcher
1Department of Medicine, Tulane Medical Center, New Orleans, La.
International Archives of Allergy and Applied Immunology
|January 1, 1988
Summary
Mushroom spore extracts show significant cross-reactivity, indicating shared allergens. This research suggests developing diagnostic tools for individuals sensitive to mushroom spores.
Area of Science:
- Mycology
- Immunology
- Allergology
Background:
- Mushroom spore allergies are a growing concern.
- Understanding cross-reactivity between different mushroom species is crucial for accurate diagnosis and treatment.
Purpose of the Study:
- To investigate the antigenic and allergenic relationships among spore extracts from various mushroom species.
- To identify shared and unique allergenic epitopes.
Main Methods:
- Ouchterlony double immunodiffusion assays were used to assess antigenic relationships.
- Radioallergosorbent testing (RAST) inhibition was employed to evaluate allergenic cross-reactivity.
- Quantitative analysis of dose-response curves determined inhibitor potencies (IC-50).
Main Results:
- Ouchterlony tests revealed a high degree of cross-antigenicity among mushroom spore extracts, with some unique antigens also detected.
- RAST inhibition showed varying potency of inhibition, with Psilocybe cubensis being the most potent inhibitor and Pisolithus tinctorius the least.
- Qualitative and quantitative differences in allergens were identified through dose-response analysis.
Conclusions:
- Mushroom spore extracts share common allergenic epitopes, explaining cross-reactivity.
- These findings support the development of standardized extract panels for diagnosing and treating mushroom spore allergies.